CureMatch Partnering With Patient Power To Educate And Empower Patients And Oncologists Regarding Personalized Cancer Treatments Post author:Sam Post published:March 29, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Revolution Medicines Appoints Cancer Leader Dr. As President Of Research And Development March 19, 2017 Biotech Bestie Celgene Takes Stake, Inks $1 Billion+ Deal With BeiGene July 5, 2017 Envisia Therapeutics Releases Interim ENV515 (Travoprost XR) Phase II Data Demonstrating 11-Month Duration-Of-Action After A Single Dose In Patients With Glaucoma February 2, 2017
Revolution Medicines Appoints Cancer Leader Dr. As President Of Research And Development March 19, 2017
Envisia Therapeutics Releases Interim ENV515 (Travoprost XR) Phase II Data Demonstrating 11-Month Duration-Of-Action After A Single Dose In Patients With Glaucoma February 2, 2017